View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, April 10 (HealthDay News) -- Lung cancer screening with low-dose spiral computed tomography could be of substantial value in high-risk smoker populations over the age of 50, and commercial insurers should consider providing coverage for the screening, according to a study published in the April issue of Health Affairs.
Bruce S. Pyenson, from the actuarial and consulting firm Milliman in New York City, and colleagues used actuarial models to evaluate the costs and benefits of offering annual lung cancer screening as a commercial insurance benefit in the high-risk U.S. population (ages 50 to 64 years). Current commercial reimbursement rates for treatment were used.
The researchers found that the cost of screening would be about $1 per month in 2012 dollars for each insured member. The cost per life-year saved would be less than $19,000, which is comparable with screening costs for cervical, breast, and colorectal cancers.
"Our results suggest that commercial insurers should consider lung cancer screening of high-risk individuals to be high-value coverage and provide it as a benefit to people who are at least 50 years old and have a smoking history of thirty pack-years or more," the authors write.
One of the authors holds patents related to lung cancer care; these patents do not involve the use of low-dose spiral computed tomography.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top